Sign in

CIK 0000948320 · Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
760238453
Phone
(866) 351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-21 Galluppi Stefan Chief Innovation Officer Grant or award +30,000 42,449
2024-03-21 Benathen Marc David Chief Financial Officer Grant or award +75,000 302,554
2024-03-21 Alvarez Nicholas P Chief Acquisition Officer Grant or award +75,000 405,000
2024-03-13 BHATIA NAVEEN Director Other acquisition +750 488,099
2024-03-07 Alvarez Nicholas P Chief Acquisition Officer Grant or award +100,000 505,000
2023-11-13 Schreiber Justin Chief Executive Officer Grant or award +50,000 2,894,620
2023-11-07 STAN MARIA E. Chief Accounting Officer Grant or award +40,000 127,500
2023-11-07 STAN MARIA E. Chief Accounting Officer Grant or award +40,000 167,500
2023-11-06 Jindal Piyush Director Option exercise +37,500 $2.52 $95K 337,500
2023-11-06 Jindal Piyush Director Option exercise · Stock Option (Right to Buy) −37,500 0
2023-08-31 Velge Bertrand Director Purchase +60,000 $3.93 $236K 349,482
2023-08-30 Velge Bertrand Director Purchase +40,000 $3.76 $150K 289,482
2023-08-29 Velge Bertrand Director Purchase +32,072 $3.58 $115K 249,482
2023-08-25 Strawn John R Jr Director Grant or award +50,000 333,347
2023-08-21 Simon Roberto Director Grant or award +50,000 100,000
2023-07-28 Mironov Alexander President Grant or award +50,000 124,857
2023-07-12 Alvarez Nicholas P Chief Acquisition Officer Grant or award +150,000 330,000
2023-07-12 Alvarez Nicholas P Chief Acquisition Officer Returned to the company · Employee Stock Option (Right to Buy) −200,000 0
2023-07-11 Benathen Marc David Chief Financial Officer Grant or award +125,000 202,554
2023-07-11 Benathen Marc David Chief Financial Officer Option exercise +25,000 227,554

Page 5 of 8 · 146 trades